Apollo Endosurgery to Present at Lake Street's 5th Annual Best Ideas Growth Conference
Apollo Endosurgery, a leader in less invasive medical devices, will participate in Lake Street's 5th Annual Best Ideas Growth Conference on September 14-15, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Apollo Endosurgery, a leader in less invasive medical devices, will participate in Lake Street's 5th Annual Best Ideas Growth Conference on September 14-15, 2021. This virtual event will feature management teams from over 100 small-cap public companies engaging with 300 institutional investors. Apollo offers innovative therapies for gastrointestinal issues and obesity, marketed in over 75 countries. Investors can reach out to Lake Street representatives or Apollo's investor relations for attendance and meeting arrangements.
Details
News Market Reaction – APEN
The recorded move for APEN in the trading session of this news was -1.81%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
AUSTIN, TX / ACCESSWIRE / September 13, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that its management team will participate in Lake Street's 5th Annual Best Ideas Growth Conference.
September 14-15, 2021
Lake Street's 5th Annual Best Ideas Growth Conference
Management teams from over 100 dynamic small-cap publicly traded companies will interact with over 300 institutional investors in a one-on-one conference format.
Investors interested in attending the virtual presentation or arranging meetings should contact their respective Lake Street representative or Apollo's investor relations, Matt Kreps and Jason Loeb of Darrow Associates, mkreps@darrowir.com, jloeb@darrowir.com.
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal complications to the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Apollo's common stock is traded on the Nasdaq Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.
Contacts:
Apollo Endosurgery, Inc.
Jeff Black, 512-279-5100
investor-relations@apolloendo.com
Darrow Associates Investor Relations
Matt Kreps, 214-597-8200
mkreps@darrowir.com
Jason Loeb, 917-579-3394
jloeb@darrowir.com
SOURCE: Apollo Endosurgery, Inc.
View source version on accesswire.com:
https://www.accesswire.com/663626/Apollo-Endosurgery-to-Present-at-Lake-Streets-5th-Annual-Best-Ideas-Growth-Conference
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.